|
Boğaziçi University Center for Targeted Therapy Technologies (Boğaziçi CT3) Has obtained the OECD Good Laboratory Practice (GLP) Certificate! |
|
|
ollowing an intensive effort and a meticulously managed process, our laboratory has been authorized under the OECD Good Laboratory Practice (GLP) Statement of Compliance in three main areas: |
|
|
|
· Physico-Chemical Testing |
|
|
· Residue Studies |
|
|
· Analytical and Clinical Chemical Testing |
|
This statement further strengthens our commitment to reliability, traceability, and international compliance in our work, and will provide significant momentum to the R&D capacity of our ecosystem—helping next-generation healthcare solutions reach the clinic faster. |
|
|
Within the scope of Good Laboratory Practice, and with our advanced analytical systems, we serve as a reliable solution partner for both scientific research and industrial needs, offering services in the following areas of expertise: |
|
|
|
· Extractables & Leachables (E&L) studies for medical devices |
|
|
· Pharmacokinetic (PK) studies in pharmaceutical samples |
|
|
· Nitrosamine impurity determination |
|
|
· Elemental impurity analyses |
|
|
· Residual solvent analyses |
|
|
· Active Pharmaceutical Ingredient (API) and related impurity analyses |
|
With our high-accuracy, fully traceable instrumentation, we provide comprehensive and robust analytical services—particularly in pharmaceutical and biomedical research. |
|
|
For detailed information and service requests, please contact us: [email protected] |
|
10.12.2025